基于美国国家监测数据2016至2018年辅助生殖技术后活产的预测概率
本研究利用美国国家辅助生殖技术监测系统2016至2018年数据,纳入196,916名女性自体胚胎移植周期及25,831名供卵移植周期,建立多项式逻辑回归模型预测累积活产率。模型显示女性年龄与累积活产率关联最强,并给出不同年龄、体重指数、不孕诊断下1至3次取卵或移植后的累积活产率估计。
要点
- 女性年龄是与累积活产率关联最强的因素。
- 新患者35岁、体重指数25 kg/m2、无既往妊娠、不明原因不孕,第1、2、3次取卵后累积活产率分别为48%、69%、80%。
- 供卵患者中极少数受者特征与累积活产率相关。
核心结论
- 模型基于人口学和生殖特征提供累积活产率估计,帮助患者和医生了解体外受精的成功概率。
研究设计与样本
- 基于人群的队列研究,使用美国国家辅助生殖技术监测系统2016至2018年数据,包括196,916名女性接受207,766个自体胚胎移植周期和25,831名女性接受36,909个供卵移植周期。
- 使用自体体外受精周期数据建立模型,估计新患者和复诊患者在1、2、3次取卵后12个月内所有胚胎移植(新鲜和冷冻)后的累积活产率。
- 供卵患者中估计第1、2、3次胚胎移植后的累积活产率。
- 采用多项式逻辑回归模型,调整年龄、孕前体重指数(对18%缺失值进行插补)、产次、孕次和不孕诊断。
主要发现
- 在自体体外受精的新患者和复诊患者中,女性年龄与累积活产率关联最强。
- 较低体重指数和产次或孕次≥1与较高累积活产率相关,但结果不一致。
- 卵巢储备功能减退、子宫因素和其他原因的不孕诊断与较低累积活产率相关,而男方因素、输卵管因素、排卵障碍和不明原因不孕与较高累积活产率相关。
- 新患者35岁、体重指数25 kg/m2、无既往妊娠、不明原因不孕,第1、2、3次取卵后累积活产率分别为48%、69%、80%。
- 若患者有卵巢储备功能减退,相应累积活产率分别为29%、48%、62%;若患者40岁(不明原因不孕),分别为25%、41%、52%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: As the use of in vitro fertilization continues to increase in the United States, up-to-date models that estimate cumulative live birth rates after multiple oocyte retrievals and embryo transfers (fresh and frozen) are valuable for patients and clinicians weighing treatment options. OBJECTIVE: This study aimed to develop models that generate predicted probabilities of live birth in individuals considering in vitro fertilization based on demographic and reproductive characteristics. STUDY DESIGN: Our population-based cohort study used data from the National Assisted Reproductive Technology Surveillance System 2016 to 2018, including 196,916 women who underwent 207,766 autologous embryo transfer cycles and 25,831 women who underwent 36,909 donor oocyte transfer cycles. We used data on autologous in vitro fertilization cycles to develop models that estimate a patient's cumulative live birth rate after all embryo transfers (fresh and frozen) within 12 months after 1, 2, and 3 oocyte retrievals in new and returning patients. Among patients using donor oocytes, we estimated the cumulative live birth rate after their first, second, and third embryo transfers. Multinomial logistic regression models adjusted for age, prepregnancy body mass index (imputed for 18% of missing values), parity, gravidity, and infertility diagnoses were used to estimate the cumulative live birth rate. RESULTS: Among new and returning patients undergoing autologous in vitro fertilization, female age had the strongest association with cumulative live birth rate. Other factors associated with higher cumulative live birth rates were lower body mass index and parity or gravidity ≥1, although results were inconsistent. Infertility diagnoses of diminished ovarian reserve, uterine factor, and other reasons were associated with a lower cumulative live birth rate, whereas male factor, tubal factor, ovulatory disorders, and unexplained infertility were associated with a higher cumulative live birth rate. Based on our models, a new patient who is 35 years old, with a body mass index of 25 kg/m2, no previous pregnancy, and unexplained infertility diagnoses, has a 48%, 69%, and 80% cumulative live birth rate after the first, second, and third oocyte retrieval, respectively. Cumulative live birth rates are 29%, 48%, and 62%, respectively, if the patient had diminished ovarian reserve, and 25%, 41%, and 52%, respectively, if the patient was 40 years old (with unexplained infertility). Very few recipient characteristics were associated with cumulative live birth rate in donor oocyte patients. CONCLUSION: Our models provided estimates of cumulative live birth rate based on demographic and reproductive characteristics to help inform patients and providers of a woman's probability of success after in vitro fertilization.
引用
- Gaskins AJ, Zhang Y, Chang J, et al. Predicted probabilities of live birth following assisted reproductive technology using United States national surveillance data from 2016 to 2018. Am J Obstet Gynecol. 2023. PMID: 36702210. doi:10.1016/j.ajog.2023.01.014
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。